Investigating how oxidative stress affects heart damage from doxorubicin in different racial groups
Role of oxidative stress in doxorubicin-induced cardiotoxicity racial disparities
This study is looking into why African Americans may have more heart problems from the cancer drug doxorubicin than White Americans, by exploring how a specific gene and oxidative stress affect heart cells, using samples from both groups to find out what makes their responses different.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Louisiana State Univ Hsc Shreveport NIH-funded |
| Lab location | 1 site (Shreveport, United States) |
| Project ID | NIH-10994899 on NIH RePORTER |
What this research studies
This research focuses on understanding why African Americans experience higher rates of heart damage from the cancer drug doxorubicin compared to White Americans. It examines the role of oxidative stress and a specific gene, EPHA2.AS1, which may influence how heart cells respond to the drug. By using patient-specific heart cells derived from both African American and White American individuals, the study aims to identify differences in cellular responses and potential genetic factors that contribute to this disparity. The research employs advanced techniques to measure oxidative stress and its effects on heart function.
Who could benefit from this research
Good fit: Ideal candidates for this research include African American and White American individuals who have been treated with doxorubicin or are at risk of receiving this treatment.
Not a fit: Patients who are not receiving doxorubicin or do not have a history of heart issues related to cancer treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for preventing heart damage in patients receiving doxorubicin, particularly among African Americans.
How similar studies have performed: Previous research has indicated that oxidative stress plays a significant role in drug-induced cardiotoxicity, suggesting that this approach may yield valuable insights.
Where this research is happening
Shreveport, United States
- Louisiana State Univ Hsc Shreveport — Shreveport, United States (Active)
Researchers
- Principal investigator: Mohamed, Tarek Magdy — Louisiana State Univ Hsc Shreveport
- Study coordinator: Mohamed, Tarek Magdy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.